Handersson Barros
Psychologist and psychotherapist
Data updated
Research Footprint
Handersson Barros appears in 5 tracked papers (2024–2026), most studied alongside DMT, Placebo and Psilocybin, across Healthy Volunteers, Depressive Disorders and Anxiety Disorders.
Most-cited paper: Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression (27 citations).
Frequent co-authors: Fernanda Palhano-Fontes, Isabel Wießner and Raynara Bolcont.
Background & Research
Handersson Barros de Freitas is a Brazilian psychologist trained at UFRN, with graduate training in health sciences and work focused on harm reduction and psychedelic-assisted treatment for mental disorders. He appears as a coauthor on multiple vaporized DMT studies from the CAMP/UFRN research group, including phase I and phase 2a clinical work and a review on DMT, madness, healing, and mystical experience.
Key Impact
He is a named coauthor on early clinical DMT studies, including safety and antidepressant-effect trials, indicating direct involvement in psychedelic clinical research.
Collaboration Network
11 collaborators· click a node to visit their profile
Full network →